1. Home
  2. CHEK vs APDN Comparison

CHEK vs APDN Comparison

Compare CHEK & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • APDN
  • Stock Information
  • Founded
  • CHEK 2004
  • APDN 1983
  • Country
  • CHEK Israel
  • APDN United States
  • Employees
  • CHEK N/A
  • APDN N/A
  • Industry
  • CHEK Medical Electronics
  • APDN Other Consumer Services
  • Sector
  • CHEK Health Care
  • APDN Consumer Discretionary
  • Exchange
  • CHEK Nasdaq
  • APDN Nasdaq
  • Market Cap
  • CHEK 4.4M
  • APDN 4.2M
  • IPO Year
  • CHEK 2015
  • APDN N/A
  • Fundamental
  • Price
  • CHEK N/A
  • APDN $4.50
  • Analyst Decision
  • CHEK
  • APDN
  • Analyst Count
  • CHEK 0
  • APDN 0
  • Target Price
  • CHEK N/A
  • APDN N/A
  • AVG Volume (30 Days)
  • CHEK 28.3K
  • APDN 140.8K
  • Earning Date
  • CHEK 08-14-2025
  • APDN 08-07-2025
  • Dividend Yield
  • CHEK N/A
  • APDN N/A
  • EPS Growth
  • CHEK N/A
  • APDN N/A
  • EPS
  • CHEK N/A
  • APDN N/A
  • Revenue
  • CHEK N/A
  • APDN $3,790,616.00
  • Revenue This Year
  • CHEK N/A
  • APDN $57.08
  • Revenue Next Year
  • CHEK N/A
  • APDN $40.00
  • P/E Ratio
  • CHEK N/A
  • APDN N/A
  • Revenue Growth
  • CHEK N/A
  • APDN N/A
  • 52 Week Low
  • CHEK $0.56
  • APDN $4.37
  • 52 Week High
  • CHEK $3.04
  • APDN $2,655.00
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 41.81
  • APDN 35.16
  • Support Level
  • CHEK $0.75
  • APDN $4.38
  • Resistance Level
  • CHEK $0.86
  • APDN $5.10
  • Average True Range (ATR)
  • CHEK 0.03
  • APDN 0.53
  • MACD
  • CHEK 0.00
  • APDN 0.40
  • Stochastic Oscillator
  • CHEK 19.59
  • APDN 22.32

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: